Biosearch Italia announces North American licensing agreement
Biosearch Italia SpA has signed a licensing agreement for North American rights to its Phase III product Ramoplanin with Genome Therapeutics Corp.
10-Oct-2001 -
Ramoplanin is a novel antibiotic for the prevention of bloodstream infections caused by vancomycin-resistant enterococci (VRE), an increasingly prevalent bacteria in certain at-risk groups, such as immunocompromised patients. If approved, Ramoplanin will be the first available antibiotic ...
antibiotics
bacteria
biotechnology
+6